Abstract. Genetic variation for seed mass and components of early vigour were measured on 120 seedlings of each of 18 diploid and 27 tetraploid perennial ryegrass (Lolium perenne L.) cultivars. Seeds of tetraploid cultivars were on average heavier (3.8 mg) than seed of diploid cultivars (2.4 mg). However, there was variation for mean seed mass both within and between ploidy classes and within cultivars. The components of early vigour measured on each of the seedlings were: date of emergence, leaf appearance rate, seedling height (10 days after germination), leaf length and width and dry matter at 33 days after emergence. Mean seed mass of a cultivar was significantly (P<0.05) positively correlated with seedling height, leaf length, leaf width, shoot length and shoot mass. Individual seed mass within a cultivar was significantly associated with all components of early vigour, except the date of emergence of the second true leaf. There was no difference in the rate of emergence of tetraploid and diploid cultivars, although tetraploid cultivars tended to have longer and wider leaves, greater seedling lengths and fewer leaves and tillers than diploid cultivars. There was also evidence of genetic variation for seedling vigour components in perennial ryegrass after seed mass and ploidy effects had been removed during analysis. These data suggest that seed mass has a large positive effect on early vigour of both diploid and tetraploid cultivars of perennial ryegrass and that, in the absence of any specific knowledge of the early vigour characteristics of a given cultivar, seed mass could be used as a surrogate when choosing between cultivars with similar adaptation and performance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.